Cancer Liver

Lewis Roberts, MB, Ph.D., a Mayo Clinic gastroenterologist, describes the significance of research results from a study involving the use of the drug sorafenib for treating advanced liver cancer, and explains why even a three-month improvement in survival is significant at this point in liver cancer research, as it is comparable to the advances that were made a decade ago in treating colon cancer. For more information, go to newsblog.mayoclinic.org